Amarin Corporation is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products to improve cardiovascular health

The company’s flagship product targets specific cardiovascular conditions and aims to provide effective solutions supported by rigorous clinical research. Amarin is dedicated to advancing the science of lipid management, enhancing treatment options for patients, and addressing key unmet medical needs in the cardiovascular space. Through its commitment to research and development, Amarin seeks to expand its product offerings and improve health outcomes for individuals at risk of cardiovascular diseases.